Hansa Biopharma AB

Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe. The company offers Idefirix(imlifidase), which targets and cleaves all classes of immunoglobulin G (IgG) antibodies for the desensitization treatment of sensitized adult kidney transplant patients with a positive crossmatch test. It also develops HNSA-5487, a next generation IgG-cleaving enzyme to address acute and chronic neuro-autoimmune conditions, including myasthenia gravis. In addition, the company evaluates imlifidase in three therapy areas, including autoimmune, gene therapy, and transplantation. It has a collaboration agreement with Sarepta Therapeutics to assess imlifidase as a pre-treatment in limb-girdle muscular dystrophy (LGMD) and duchenne muscular dystrophy (DMD) and research and development collaboration agreement with Genethon to evaluate the safety and efficacy of imlifidase as pre-treatment to gene therapy in Crigler-Najjar syndrome patients with anti-AAV antibodies. Hansa Biopharma AB (publ) was formerly known as Hansa Medical AB (publ) and changed its name to Hansa Biopharma AB (publ) in December 2018. Hansa Biopharma AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.

0RC7.LSE▲

Empire State Realty Trust signs Instacart lease, lifts 111 W. 33rd Street to full occupancy

Empire State Realty Trust signed a new office lease with Instacart for 26,134 square feet at 111 West 33rd Street in the second quarter. The company also signed a 7,100-square-foot lease with Hansa Biopharma early in the third quarter, bringing 111 West 33rd Street to 100% leased. Additionally, 1350 Broadway is now fully leased following 12 new leases and tenant expansion deals over the past 12 months. Executive Vice President and Chief Revenue Officer Ryan Kass said the full occupancy at both properties reflects strong demand for Manhattan office space in New York City, while noting the company still has two large office spaces available for lease in 2026.

0RC7.LSE ▲CART ▲

Seeking Alpha·37dRead more ▾